Executive Order April 07, 2025 Doc #2025-06027 Executive Order 14256

Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports

Trade Public Safety Foreign Policy Economy

💡

In Simple Terms

The President has ordered new fees on small packages from China and Hong Kong to stop illegal drugs from entering the U.S. These packages will no longer be exempt from duties, and carriers must pay these fees when bringing packages into the country.

Summary

On April 2, 2025, President Donald Trump issued Executive Order 14256, which amends duties on low-value imports from the People's Republic of China (PRC) to combat the synthetic opioid crisis. This order eliminates the duty-free de minimis exemption for certain low-value products from China and Hong Kong, requiring these imports to be subject to duties when they enter the United States after May 2, 2025. The order mandates that U.S. Customs and Border Protection (CBP) collect these duties and allows for either a 30% ad valorem duty or a specific duty of $25 or $50 per item, depending on the date of entry. This action aims to address deceptive shipping practices that facilitate the entry of illicit substances into the U.S. while maintaining the flow of legitimate international mail.

Official Record

Federal Register Published

Signed by the President

April 02, 2025

Published in Federal Register

View on Federal Register View Printed Version (PDF)

April 07, 2025

Document #2025-06027

Analysis & Impact

💡 How This May Affect You

This executive order aims to address the synthetic opioid crisis by imposing new duties on low-value imports from China and Hong Kong, specifically targeting goods that might otherwise avoid tariffs due to their low declared value. Here’s how this policy could affect different groups of Americans:

Working Families and Individuals

Daily Life and Finances: Families who frequently purchase low-cost goods from China, such as electronics, clothing, or household items, might see an increase in prices. This could strain budgets, especially for those who rely on affordable imports for necessities.
Example: If a family regularly orders small electronics or gadgets online from Chinese retailers, they might notice these items becoming more expensive due to the new duties.

Small Business Owners

Operational Costs: Small businesses that rely on importing low-cost goods from China for resale or as components for their products will face higher costs. This could lead to increased prices for consumers or squeezed profit margins for business owners.
Example: A small online retailer that sources products from China may need to reassess their pricing strategy or find alternative suppliers to maintain profitability.

Students and Recent Graduates

Finances and Opportunities: Students and recent graduates who purchase affordable electronics or other goods online may face higher costs. Additionally, those in fields related to international trade or logistics might find new job opportunities as companies adjust to the new regulations.
Example: A student buying a low-cost smartphone from an international seller might pay more, affecting their budget for other essentials.

Retirees and Seniors

Fixed Incomes: Retirees on fixed incomes who purchase low-cost goods from China might experience financial pressure due to rising prices. However, some might benefit from improved safety if these measures effectively reduce opioid trafficking.
Example: A retiree who frequently buys inexpensive health and wellness products online may need to adjust their spending.

Geographic Regions

Urban Areas: Consumers in urban areas, who often have more access to international online shopping, might feel the impact of increased prices more acutely. However, urban centers might also benefit from increased law enforcement resources and reduced drug trafficking.
Suburban Areas: Suburban consumers who rely on online shopping for convenience could see higher prices but might also benefit from improved local economies if domestic businesses grow in response to import changes.
Rural Areas: Rural areas might experience mixed effects. While residents might face higher costs for imported goods, local businesses could benefit if they can offer competitive alternatives. Additionally, rural areas might see reduced drug-related issues if the policy effectively curtails opioid imports.

Overall, while the executive order aims to curb the opioid crisis by increasing oversight and duties on imports, it also introduces potential economic challenges for consumers and businesses dependent on low-cost imports. The real-world implications will vary based on individual circumstances, such as reliance on imported goods and the ability to adapt to price changes.

🏢 Key Stakeholders

Primary Beneficiaries:

U.S. Law Enforcement and Public Health Agencies: Agencies such as the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) will benefit from reduced synthetic opioid imports, aiding in their mission to combat the opioid crisis and protect public health.
Domestic Manufacturers and Retailers: U.S.-based companies may benefit from reduced competition from low-value Chinese imports, potentially increasing domestic sales and market share.

Stakeholders Facing Challenges:

Chinese Exporters and Shippers: These businesses will face increased duties and regulatory hurdles, likely reducing their competitiveness in the U.S. market and impacting their revenue.
U.S. Consumers: Consumers may experience higher prices for goods previously imported duty-free from China, affecting affordability and availability of certain products.

Industries, Sectors, or Professions Most Impacted:

Logistics and Transportation: Companies involved in international shipping and logistics will need to adapt to new duty collection processes and reporting requirements, potentially increasing operational costs.
E-commerce Platforms: Online retailers that rely on low-cost imports from China may face increased costs and complexity, impacting their pricing strategies and profit margins.

Government Agencies or Departments Involved in Implementation:

U.S. Customs and Border Protection (CBP): CBP will be responsible for implementing and enforcing the new duties, requiring additional resources and coordination with other agencies.
Department of Commerce: This department will monitor the impact of the order and report on its effects, playing a key role in assessing and potentially recommending further actions.

Interest Groups, Advocacy Organizations, or Lobbies with Strong Positions:

Trade Associations: Groups representing importers and retailers, such as the National Retail Federation, may oppose the action due to increased costs for members.
Public Health Advocacy Groups: Organizations focused on combating the opioid crisis, such as the Partnership to End Addiction, are likely to support the action as a measure to reduce opioid availability.

Each stakeholder group cares about this action due to its direct impact on their operations, financial outcomes, or mission objectives, influencing their support or opposition to the policy change.

📈 What to Expect

Short-term (3-12 months):

Immediate Implementation Steps:
- The Department of Homeland Security, through U.S. Customs and Border Protection (CBP), will need to quickly establish protocols for collecting duties on low-value imports from China and Hong Kong. This includes setting up systems to process the new duty rates and ensuring that all carriers are informed and compliant with the new regulations.
- CBP will likely issue guidance and regulations to carriers, requiring them to report and remit duties on international postal packages from China and Hong Kong. This may involve adjustments to the Automated Commercial Environment (ACE) system.
Early Visible Changes or Effects:
- An immediate increase in the cost of low-value imports from China and Hong Kong, as duties are applied to previously duty-free items.
- Potential delays in processing international postal packages as carriers and CBP adjust to the new requirements.
- Possible reduction in the volume of low-value imports from China and Hong Kong as the cost increases for consumers and businesses.
Potential Initial Reactions or Challenges:
- Businesses that rely on low-value imports from China may express concerns or lobby for exemptions or modifications to the policy.
- Carriers and logistics companies might face operational challenges and increased administrative burdens to comply with the new reporting and duty collection requirements.
- There could be diplomatic tensions with China and Hong Kong, as the policy directly targets their exports.

Long-term (1-4 years):

Broader Systemic Changes:
- The policy could lead to a re-evaluation and potential restructuring of supply chains, with businesses seeking alternative sources for low-value goods to avoid the additional duties.
- A potential decrease in the importation of synthetic opioids, if the policy effectively disrupts the supply chain from China, contributing to a reduction in opioid-related issues in the U.S.
Cumulative Effects on Society, Economy, or Policy Landscape:
- A shift in consumer behavior as the cost of goods from China increases, potentially leading to a greater emphasis on domestic production or sourcing from other countries.
- Over time, there may be a measurable impact on the synthetic opioid crisis if the policy successfully curtails the influx of these substances through low-value shipments.
- The policy could set a precedent for similar actions against other countries or industries perceived as contributing to public health crises.
Potential for Modification, Expansion, or Reversal by Future Administrations:
- Future administrations might modify or expand the policy based on its effectiveness in reducing synthetic opioid imports and its impact on trade relations and the economy.
- If the policy proves ineffective or overly burdensome on businesses and consumers, there could be calls for its reversal or significant amendment.
- The policy could be expanded to include other regions or products if there is evidence of circumvention or if similar issues arise with other countries.

Overall, this executive order is a strategic move to address the synthetic opioid crisis by targeting a known supply chain vulnerability. While it may face challenges and adjustments in the short term, its long-term success will depend on its ability to disrupt illicit trade without unduly harming legitimate commerce and international relations.

📚 Historical Context

The executive order titled "Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports" represents a significant step in U.S. policy aimed at mitigating the synthetic opioid crisis by targeting the supply chain, particularly focusing on imports from China. This action fits into a broader historical context of U.S. presidents using executive powers to address pressing public health and economic issues through trade and import regulations.

Historical Precedents and Similar Actions:

Trade and National Security: The use of trade measures to address national security concerns, including public health crises, has historical precedents. For instance, President Donald Trump used tariffs under the guise of national security to impose duties on steel and aluminum imports in 2018, citing the need to protect domestic industries and ensure national security.
War on Drugs: The U.S. government's efforts to combat drug trafficking date back to the 20th century, with significant actions under Presidents Richard Nixon and Ronald Reagan. Nixon declared a "war on drugs" in 1971, emphasizing law enforcement, while Reagan intensified these efforts through legislation and international cooperation to curb drug supply chains.
Addressing Deceptive Practices: The focus on deceptive shipping practices echoes past efforts to combat illegal trade practices. For example, during the 1980s, the Reagan administration targeted counterfeit goods and intellectual property theft, often linked to deceptive import practices.

Building Upon, Modifying, or Reversing Policies:

This executive order builds upon prior actions taken by the administration earlier in 2025, as noted by the references to previous executive orders (14195, 14228, and 14200). These orders progressively increased scrutiny and duties on imports from China related to synthetic opioids, reflecting a strategy of escalating economic pressure to address the opioid crisis.

Relevant Historical Patterns:

Escalating Tariffs as Leverage: The use of tariffs and duties as leverage in international relations is a recurring theme in U.S. policy. Historically, tariffs have been employed not just for revenue but as tools for negotiation and enforcement, such as during the Smoot-Hawley Tariff Act of 1930, which aimed to protect American industries during the Great Depression.
Targeting Specific Countries: The focus on China as a source of synthetic opioids is consistent with recent U.S. trade policies that have singled out specific countries for economic sanctions or increased duties, particularly when addressing intellectual property theft or unfair trade practices.

Unique and Noteworthy Aspects:

Targeting Low-Value Imports: The specific targeting of low-value imports, typically exempt from duties under the de minimis threshold, is a novel approach. This reflects a strategic shift to close loopholes that have been exploited for illegal activities, demonstrating a nuanced understanding of contemporary trade practices.
Integration of Technology in Enforcement: The order's emphasis on using the Automated Commercial Environment (ACE) and requiring carriers to report electronically highlights the increasing role of technology in customs enforcement, aligning with broader trends in digital transformation within government operations.
Public Health and Trade Policy Intersection: This action underscores the intersection of public health and trade policy, illustrating how economic tools are being leveraged to address health crises, a relatively recent development in policy-making that reflects the complex, global nature of modern challenges.

In summary, this executive order is a continuation of a long-standing tradition of using trade policy to achieve broader national objectives, adapted to the specific challenges of the 21st century, such as the opioid crisis and international supply chain complexities. It represents a strategic use of executive power to address a pressing public health issue, drawing from historical practices while incorporating modern technological and regulatory frameworks.

Affected Agencies

Department of Homeland Security U.S. Customs and Border Protection Department of Commerce Department of the Treasury Department of Justice United States Trade Representative United States International Trade Commission